Based on our data, we conclude that MIR4435-2HG exerts versatile functions in bladder cancer by transcriptionally regulating the expression of multiple cell-cycle regulators such as CCND1 and BRCA2. Here, BRCA2 is linked to urinary bladder carcinoma.